Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data

被引:1
|
作者
Whitson, Jared M. [1 ]
Meng, Maxwell [1 ]
机构
[1] Kaiser Permanente South Sacramento Med Ctr, Dept Urol, Sacramento, CA USA
关键词
extent; lymph node dissection; nephrectomy; renal cell carcinoma; survival;
D O I
10.1111/j.1464-410X.2012.11718.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A recent population-based analysis suggested a potential survival benefit with respect to performing lymph node dissection at nephrectomy in node-positive patients with RCC. The findings of the present study failed to corroborate the association of a survival benefit with the performance of lymph node dissection at nephrectomy. Objective Previous studies showed no survival benefit with respect to performing lymph node dissection (LND) at nephrectomy, whereas a recent population-based analysis suggested otherwise, although the latter relied on imputation. To reconcile the findings of that study by critically evaluating the handling of missing data. Patients and Methods Study participants comprised patients diagnosed with non-metastatic renal cell carcinoma (RCC) of all stages who underwent LND at nephrectomy (n = 10596). Multivariable Cox regression models were performed to predict cancer-specific mortality (CSM), where the primary variable of interest was the extent of LND. To examine differences in approaches with respect to handling missing data, separate analyses were performed: (i) imputed population; (ii) exclusion of patients with missing data; and (iii) inclusion of patients with missing data as a sub-category. Results Overall, 2916 (28%) patients had missing tumour grade. In multivariable analyses, our findings showed that increasing the extent of LND was associated with a significant protective effect on CSM in patients with pN1 after imputation (hazard ratio [HR], 0.82; P = 0.04). By contrast, the extent of LND was no longer significantly associated with a lower risk of CSM after excluding patients with a missing tumour grade (HR, 0.83; P = 0.1) or when including patients with missing tumour grade as a sub-category (HR, 0.82; P = 0.05). Conclusions The findings of the present study failed to corroborate the association of a survival benefit with increasing extent of LND at nephrectomy. The different methodologies employed to account for missing data may introduce important biases. Such considerations are non-negligible with respect to the interpretation of results for investigators who rely on administrative cohorts.
引用
收藏
页码:2 / 3
页数:2
相关论文
共 50 条
  • [1] LYMPHADENECTOMY IMPROVES SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND NODAL METASTASES
    Whitson, Jared
    Harris, Catherine
    Reese, Adam
    Meng, Maxwell
    JOURNAL OF UROLOGY, 2011, 185 (04): : E668 - E669
  • [2] Lymphadenectomy Improves Survival of Patients With Renal Cell Carcinoma and Nodal Metastases
    Whitson, Jared M.
    Harris, Catherine R.
    Reese, Adam C.
    Meng, Maxwell V.
    JOURNAL OF UROLOGY, 2011, 185 (05): : 1615 - 1620
  • [3] Does lymphadenectomy improve cancer-specific survival in patients with renal cell carcinoma?
    Robert C Flanigan
    Nature Clinical Practice Urology, 2005, 2 : 588 - 589
  • [4] Does lymphadenectomy improve cancer-specific survival in patients with renal cell carcinoma?
    Flanigan, RC
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (12): : 588 - 589
  • [5] Is late ocurrence of metastases associated with prolonged survival in patients with renal cell carcinoma?
    Chromecki, Thomas
    Hutterer, Georg C.
    Kampel-Kettner, Karin
    Imamovic, Arwin
    Rehak, Peter
    Langner, Cord
    Pummer, Karl
    Zigeuner, Richard
    JOURNAL OF UROLOGY, 2008, 179 (04): : 414 - 414
  • [6] Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study
    Nilubol, Naris
    Patel, Dhaval
    Kebebew, Electron
    WORLD JOURNAL OF SURGERY, 2016, 40 (03) : 697 - 705
  • [7] Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study
    Naris Nilubol
    Dhaval Patel
    Electron Kebebew
    World Journal of Surgery, 2016, 40 : 697 - 705
  • [8] Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma
    Capitanio, Umberto
    Jeldres, Claudio
    Patard, Jean-Jacques
    Perrotte, Paul
    Zini, Laurent
    de La Taille, Alexandre
    Ficarra, Vincenzo
    Cindolo, Luca
    Bensalah, Karim
    Artibani, Walter
    Tostain, Jacques
    Valeri, Antoine
    Zigeuner, Richard
    Mejean, Arnaud
    Descotes, Jean Luc
    Lechevallier, Eric
    Mulders, Peter F.
    Lang, Herve
    Jacqmin, Didier
    Karakiewicz, Pierre I.
    BJU INTERNATIONAL, 2009, 103 (01) : 33 - 37
  • [9] Is the late occurrence of metastases associated with prolonged survival in renal cell carcinoma?
    Chromecki, T.
    Hutterer, G.
    Imamovic, A.
    Kampel-Kettner, K.
    Rehak, P.
    Langner, C.
    Pummer, K.
    Zigeuner, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 260 - 260
  • [10] Does aggressive surgical resection of metastatic renal cell carcinoma improve survival?
    Leibovich, BC
    Cheville, JC
    Lohse, CM
    Zincke, H
    Blute, ML
    JOURNAL OF UROLOGY, 2003, 169 (04): : 264 - 264